bioRxivPharmacology & ToxicologyPreprint
Multidimensional characterization of the physiological and behavioral effects of TCB-2 in mice
Mizuki YamamotoiD, Hiroto InoueiD, Kazuko HayashiiD, Illia AotaiD, Jumpei MatsumotoiD, Kota YamadaiD, Koji TodaiD
Abstract
Background and PurposeSerotonergic psychedelics affect behavior and physiology, but the relationships among these effects remain poorly understood. In rodents, the head-twitch response is used as a measure of psychedelic-like activity, yet it does not capture changes in physiological state or the performance of learned behaviors. Here, we investigated the acute effects of the 5-HT2A receptor agonist TCB-2 across several behavioral and physiological measures and examined how these effects were modified by pretreatment with the 5-HT2A receptor antagonist volinanserin. Experimental ApproachMice were tested in head-fixed and freely moving conditions. During a learned auditory trace-conditioning task, we measured licking, pupil area, eye position, and blinking. We measured locomotor activity in an open field and quantified head-twitch responses using a DeepLabCut-based method. To examine the contribution of 5-HT2A receptors, mice were pretreated with the 5-HT2A receptor antagonist volinanserin. Key ResultsTCB-2 caused pupil constriction without detectable changes in eye position or blinking when administered alone. TCB-2 also reduced licking at the highest dose, but the cue-locked temporal pattern of licking remained evident. In freely moving mice, TCB-2 reduced locomotor activity and produced a dose-dependent increase in head-twitch responses. Volinanserin partially attenuated TCB-2-induced pupil constriction and reduced head-twitch responses under some conditions, but it did not consistently prevent the other effects of TCB-2. Conclusions and ImplicationsTCB-2 produced distinct effects across physiological and behavioral measures rather than a uniform disruption of behavioral function. Pronounced pupil constriction and head-twitch responses occurred without detectable changes in eye position or blinking, while the temporal organization of conditioned licking was retained despite a reduction in its magnitude. The incomplete and variable effects of volinanserin preclude definitive conclusions about the receptor mechanisms underlying each response. Combining automated head-twitch detection with physiological and task-related measurements provides a broader framework for comparing the pharmacological profiles of serotonergic compounds. What is already knownO_LIClassical psychedelics produce characteristic effects primarily through serotonin 5-HT2A receptor activation. C_LIO_LIHead-twitch responses capture only one dimension of psychedelic-like drug action. C_LI What this study addsO_LITCB-2 reduced locomotion and licking while preserving the cue-locked pattern of conditioned licking. C_LIO_LIPupil constriction occurred without detectable changes in eye position or blinking. C_LI Clinical significanceO_LIMultidimensional phenotyping can distinguish the physiological and behavioral profiles of serotonergic compounds. C_LIO_LIComplementary measures may improve preclinical evaluation of emerging serotonergic therapeutics. C_LI
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implications.
Orr Shahar, Alexander Botvinnik, … Tzuri Lifschytz·International Journal of Molecular SciencesPeer-reviewed·Nov 16, 2022
- Activity of prefrontal cortex serotonin 2A receptor expressing neurons is necessary for the head-twitch response of mice to psychedelic drug DOI in a sex-dependent manner
Annika B. Ozols, Jing Wei, … Amelia L. Gallitano·bioRxiv·May 21, 2024
- Serotonin2A receptors in the medial prefrontal cortex do not drive DOI-induced head-twitch responses in rodents
Ratna Mahathi Vuruputuri, Vaishnavi Reghunath, … Vidita A. Vaidya·bioRxiv·Oct 11, 2026
- Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelics
Aurelija Ippolito, Sridhar R. Vasudevan, … Trevor Sharp·British Journal of PharmacologyPeer-reviewed·Jun 22, 2025
- Behavioral pharmacology of mescaline - the role of serotonin 5-HT2A, 5-HT2B, 5-HT2C and 5-HT1A receptors
Lucie Olejníková, Michaela Fujáková-Lipski, … Tomáš Páleníček·Pharmacology Biochemistry and BehaviorPeer-reviewed·Nov 14, 2024
- Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition
P. Mallaroni, N. L. Mason, … J. G. Ramaekers·bioRxiv·Feb 16, 2023